# Lisata Therapeutics, Inc.: Form 8-K, filed Jun 27, 2024

- Company: [Lisata Therapeutics, Inc.](/companies/lsta.md) (CIK 320017)
- Form: 8-K
- Filed: 2024-06-27
- Accepted by EDGAR: Jun 27, 2024, 16:53 ET
- Period: 2024-06-27
- Accession: 0000320017-24-000034
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/clbs-20240627.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/

## Items reported

- Item 2.02: Results of operations

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/320017/000032001724000034/clbs-20240627.htm

Filed Jun 27, 2024.
Source: SEC EDGAR, the filing index for accession 0000320017-24-000034. Last ingested by Listed: Nov 14, 2026, 19:21 ET. No prices; not investment advice.